VC

Valliance Capital

North America, California, United States, San Francisco

Description

Valliance Capital is an investment management firm.

Investor Profile

Valliance Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D, Private Equity rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Medical, Biotechnology, Health Care.

Stage Focus

  • Series D (50%)
  • Private Equity (50%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Medical
  • Biotechnology
  • Health Care
  • Medical Device
  • Apps
  • Delivery
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Valliance Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
FountainVest Partners
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
SC
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
TPG Capital Asia
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Redview Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Orchid Asia Group Management
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Exome Asset Management
North America, New York, United States, New York
Co-Investments: 1
Yingke Capital
Asia, Jiangxi, China, Fuzhou
Co-Investments: 1

What are some of recent deals done by Valliance Capital?

Dingdang Kuaiyao

Beijing, Beijing, China

Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform.

AppsDeliveryE-CommerceMedical
Private EquityJun 8, 2021
Amount Raised: $220,000,000
Broncus Technologies

Mountain View, California, United States

Broncus Technologies is a medical technology company developing minimally-invasive medical devices for emphysema and other lung diseases.

BiotechnologyHealth CareMedicalMedical Device
Series DJan 28, 2021

Find More Investors Like Valliance Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Valliance Capital | Pipeseed